AbbVie’s efforts to protect its megablockbuster Humira have been well documented and much maligned, and now New York’s largest grocery union is taking the drugmaker to task over its “patent thicket” and “market division” agreements.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,